Jane Preuss Hasselby

Jane Preuss Hasselby serves as a Clinical Associate Professor in the Department of Clinical Medicine, specializing in Pathology at the University of Copenhagen's Faculty of Health and Medical Sciences. She is based at Blegdamsvej 3 in Copenhagen and maintains strong affiliations with Region Hovedstaden (Region H), as evidenced by her institutional email address. Her academic position reflects her dual expertise in clinical practice and research within the Danish healthcare system.

Dr. Hasselby's research program focuses on pancreatic pathology, cancer biology, and the application of immunotherapy in gastrointestinal malignancies. Her work spans from fundamental investigations of pancreatic regeneration and injury response mechanisms to clinical studies evaluating novel cancer treatments. She has established particular expertise in pathological analysis of surgical specimens, with emphasis on margin clearance in pancreatic cancer resections and immune microenvironment characterization. Her research demonstrates strong translational value, bridging laboratory findings with clinical applications in oncology.

Analysis of her recent publications reveals a cohesive research trajectory centered on pancreatic cancer pathogenesis and treatment response. She frequently leads or contributes to multidisciplinary studies that integrate pathology, oncology, surgery, and immunology, often within the context of large Danish population-based cohorts or clinical trials. Her work shows increasing emphasis on combination immunotherapy approaches and their underlying biological mechanisms, with several publications examining how immune responses correlate with treatment outcomes in gastrointestinal cancers.

Dr. Hasselby actively participates in clinical research through collaborations with major Danish cancer centers, including involvement in multiple phase 2 clinical trials investigating novel treatment approaches for pancreatic and biliary tract cancers. Her collaborative network extends across pathology departments, oncology units, and research institutions throughout Denmark, reflecting her role as a key contributor to gastrointestinal cancer research in the Nordic region.